Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

31,500

Employees31,500

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

31,500

Employees31,500

AMGN Key Statistics

Market cap

217.73B

Market cap217.73B

Price-Earnings ratio

25.03

Price-Earnings ratio25.03

Dividend yield

2.47%

Dividend yield2.47%

Average volume

3.02M

Average volume3.02M

High today

$405.90

High today$405.90

Low today

$396.01

Low today$396.01

Open price

$402.86

Open price$402.86

Volume

2.04M

Volume2.04M

52 Week high

$447.03

52 Week high$447.03

52 Week low

$288.00

52 Week low$288.00

Stock Snapshot

As of today, Amgen(AMGN) shares are valued at $402.00. The company's market cap stands at 217.73B, with a P/E ratio of 25.03 and a dividend yield of 2.47%.

During the trading session on 2026-10-06, Amgen(AMGN) shares reached a daily high of $405.90 and a low of $396.01. At a current price of $402.00, the stock is +1.5% higher than the low and still -1.0% under the high.

Trading volume for Amgen(AMGN) stock has reached 2.04M, versus its average volume of 3.02M.

The stock's 52-week range extends from a low of $288.00 to a high of $447.03.

AMGN News

TipRanks 5h

Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race

Amgen Inc (AMGN) announced an update on their ongoing clinical study. The study, titled “A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascend...

Zacks 10h

Amgen Inc. Is a Trending Stock: Facts to Know Before Betting on It

Amgen (AMGN Quick QuoteAMGN - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some o...

The Motley Fool 2d

Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?

Biotechnology investors often compare the steady cash flows of established giants with the explosive potential of specialized innovators. Choosing between Amgen...

Analyst ratings

51%

of 37 ratings

Buy

32.4%

Hold

51.4%

Sell

16.2%

More AMGN News

Investing.com 4d

David J. Taylor Purchases Amgen and Home Depot Stocks, Sells Marathon Petroleum - Investing.com

...

TipRanks 4d

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen’s AMGN Evolocumab Study Highlights Subtle Edge in Cholesterol Drug Delivery The Am...

TipRanks 5d

Amgen’s Pediatric Psoriasis Study in Japan Wraps Up, Setting the Stage for Otezla Growth

Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 3 study called “A Phase 3, Multicenter, Open-labe...

Simply Wall St 6d

Is Amgen Undervalued Following Its Phase 3 Sjögren's Disease Trial Update?

Amgen (AMGN) is back in focus after reporting positive topline Phase 3 data from its OASIZ 301 trial of dazodalibep in Sjögren's disease, which has sharpened at...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.